BiographyDr. Werler is Professor and Chair of Epidemiology. She is a perinatal epidemiologist whose NIH- and CDC- supported research includes projects on maternal serum markers of infection and abdominal wall defects; gene-environment interactions and clubfoot; medications, folic acid intake, and inheritance in relation to spina bifida; and psycho-social and cognitive outcomes in children born with craniofacial birth defects. She has published over 175 papers and book chapters; received the National Birth Defect Prevention Network Oakley Award, the Society for Pediatric and Perinatal Epidemiologic Research Mentoring Award, and the Teratology Society Fraser Award; and served on numerous NIH advisory and review boards. Dr. Werler is Director of the BU Reproductive, Perinatal, and Pediatric Epidemiology training program for pre-doctoral candidates in Epidemiology and teaches Design and Conduct of Case-Control Studies.
- Chair, Epidemiology, Boston University School of Public Health
- Boston University, DSc
- University of Michigan at Ann Arbor, MPH
- Boston College, BS
- Published on 9/2/2020
Kerr SM, Parker SE, Mitchell AA, Tinker SC, Werler MM. Folic acid antagonist use before and during pregnancy and risk for selected birth defects. Birth Defects Res. 2020 Nov; 112(18):1526-1540. PMID: 32875745.
- Published on 7/13/2020
Hansen C, Desrosiers TA, Wisniewski K, Strickland MJ, Werler MM, Gilboa SM. Use of antihistamine medications during early pregnancy and selected birth defects: The National Birth Defects Prevention Study, 1997-2011. Birth Defects Res. 2020 Oct; 112(16):1234-1252. PMID: 32657014.
- Published on 7/4/2020
Schrager NL, Adrien N, Werler MM, Parker SE, Van Bennekom C, Mitchell AA. Trends in first-trimester nausea and vomiting of pregnancy and use of select treatments: Findings from the National Birth Defects Prevention Study. Paediatr Perinat Epidemiol. 2020 Jul 04. PMID: 32623767.
- Published on 7/1/2020
Lau B, Duggal P, Ehrhardt S, Armenian H, Branas CC, Colditz GA, Fox MP, Hawes SE, He J, Hofman A, Keyes K, Ko AI, Lash TL, Levy D, Lu M, Morabia A, Ness R, Nieto FJ, Schisterman EF, Stürmer T, Szklo M, Werler M, Wilcox AJ, Celentano DD. Perspectives on the Future of Epidemiology: A Framework for Training. Am J Epidemiol. 2020 07 01; 189(7):634-639. PMID: 32003778.
- Published on 6/23/2020
Adrien N, Petersen JM, Parker SE, Werler MM. Vasoactive exposures and risk of amniotic band syndrome and terminal transverse limb deficiencies. Birth Defects Res. 2020 Aug; 112(14):1074-1084. PMID: 32573119.
- Published on 6/1/2020
Kaelin VC, Wallace ER, Werler MM, Collett BR, Khetani MA. Community participation in youth with craniofacial microsomia. Disabil Rehabil. 2020 Jun 01; 1-8. PMID: 32478589.
- Published on 3/28/2020
Petersen JM, Esposito DB, Werler MM. Selective serotonin reuptake inhibitor use patterns among commercially insured US pregnancies (2005-2014). Arch Womens Ment Health. 2020 Mar 28. PMID: 32222834.
- Published on 3/23/2020
Parker SE, Werler MM. Prenatal exposure to acetaminophen and neurodevelopment. Paediatr Perinat Epidemiol. 2020 05; 34(3):225-226. PMID: 32201959.
- Published on 11/6/2019
Parker SE, Collett BR, Werler MM. Maternal acetaminophen use during pregnancy and childhood behavioural problems: Discrepancies between mother- and teacher-reported outcomes. Paediatr Perinat Epidemiol. 2020 05; 34(3):299-308. PMID: 31693212.
- Published on 10/3/2019
Collett BR, Chapman K, Wallace ER, Kinter SL, Heike CL, Speltz ML, Werler M. Speech, Language, and Communication Skills of Adolescents With Craniofacial Microsomia. Am J Speech Lang Pathol. 2019 11 19; 28(4):1571-1581. PMID: 31580699.
View 213 more publications:View full profile at BUMC
News & In the Media
- Published on June 26, 2020
- Published on September 6, 2018
- Published on July 9, 2018
- Published on April 4, 2016
- Published on March 3, 2016
- Published on October 30, 2015
- Published on July 9, 2015
- Published on August 12, 2014
- Published on June 2, 2014
- Published on April 15, 2014